James Paul Scopa, Director of Aligos Therapeutics ALGS, has filed 1 purchase and 1 sale on the open market. The latest trade was on 06/25.

JS

JS

James Paul Scopa

Director

Company

Aligos Therapeutics ALGS

First filing

23/03/21

Trades

36 trades

Buys / sales

1 / 1

12-month net buying

No record

Last trade

06/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AB Adverum Biotechnologies	Open-market buy	24/02/07	24/02/09	100,000 sh	$1.35	$135,000	No record
DT Dice Therapeutics	Open-market sale	23/03/17	23/03/21	10,000 sh	$29.05	$290,500	−29.7%